Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
Condition(s):Stage I Pulmonary AdenocarcinomaLast Updated:February 10, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Stage I Pulmonary AdenocarcinomaLast Updated:February 10, 2021Completed
Condition(s):Adenocarcinoma of LungLast Updated:October 15, 2021Not yet recruiting
Condition(s):Lung Adenocarcinoma, Stage ILast Updated:December 14, 2020Unknown status
Condition(s):Lung Adenocarcinoma; Radiomics; Grading SystemLast Updated:February 21, 2023Recruiting
Condition(s):Neoplasms, Therapy-AssociatedLast Updated:November 5, 2014Unknown status
Condition(s):Lung NeoplasmsLast Updated:July 20, 2023Recruiting
Condition(s):Chemotherapy, Adjuvant; Lung Adenocarcinoma, Stage I; Treatment; Histological Type of NeoplasmLast Updated:December 19, 2017Recruiting
Condition(s):Lung AdenocarcinomaLast Updated:May 15, 2023Recruiting
Condition(s):IA Lung Adenocarcinoma; Combined SegmentectomyLast Updated:August 9, 2023Active, not recruiting
Condition(s):Lung Adenocarcinoma, Stage ILast Updated:April 26, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.